Clinical Trial

Effect of Olivomed (Olive Extract) on Endothelial, Cardiac and Vascular Function

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated May 29, 2024 (before its estimated April 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
Olive extracts are considered to have antioxidant properties. The investigators will study the effect of olive extracts containing hydroxytyrosol (HT)-olivomed and combination of Oleuropein (OL), Hydroxytyrosol (HT), Oleocanthal (OC) - olivomedSmart on endothelial, cardiac and vascular function in patients with coronary artery disease .
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT04520126
Lead Sponsor University of Athens
Conditions Coronary Artery Disease
Enrollment 30 participants
Start Date 2020-12-01
Primary Completion 2025-04-10 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2024-05-29